The GLP-1/GIP dual-receptor agonist DA5-CH inhibits the NF-κB inflammatory pathway in the MPTP mouse model of Parkinson's disease more effectively than the GLP-1 single-receptor agonist NLY01.
Brain Behav
; 11(8): e2231, 2021 08.
Article
in En
| MEDLINE
| ID: mdl-34125470
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parkinson Disease
/
Pharmaceutical Preparations
/
Neuroprotective Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Brain Behav
Year:
2021
Document type:
Article
Country of publication:
Estados Unidos